High-purity peptides for Research use — fast UK delivery available.

How Ipamorelin Supports and Enhances Immune Function

Ipamorelin is a synthetic pentapeptide consisting of 5 amino acids (Aib-His-D-2-Nal-D-Phe-Lys-NH2) classified as a growth hormone secretagogue receptor (GHSR) agonist, specifically targeting the ghrelin receptor. This remarkable peptide has demonstrated significant immunomodulatory properties that extend far beyond its primary role in stimulating growth hormone production.

Mechanism of Immune Enhancement

Modulation helps in regulating immune responses, potentially enhancing defense mechanisms against pathogens while preventing excessive inflammation. Increased immunoglobulin levels improve the body’s ability to neutralize and eliminate antigens. Ipamorelin can enhance the cytotoxic activity of Natural Killer (NK) cells, which are crucial for targeting virus-infected cells.

The immunomodulatory capacity of Ipamorelin stems from the peptide’s ability to optimize growth hormone levels, which play essential roles in maintaining immune system integrity.

The GHSR Receptor and Immune Tissue Distribution

The GHSR receptor is also present in the gastrointestinal tract, immune cells, adipose tissue, kidneys, heart, lung, and liver. This widespread receptor distribution explains how Ipamorelin can exert systemic immunomodulatory effects throughout the body.

GHRPs interact with two different receptors: growth hormone secretagogue receptor 1a (GHSR-1a) and CD36. GHSR-1a, which is bound natively by ghrelin and sometimes called the “ghrelin receptor”, is expressed primarily in the brain, including the anterior pituitary gland, hippocampus, and hypothalamic arcuate nucleus. CD-36 is expressed extensively within endothelial cells, immune cells, adipocytes, cardiac and skeletal muscle, hepatocytes, and several other regions.

Cytokine Production and Immune Signaling

Higher production of cytokines leads to better immune responses. These small proteins promote tissue repair. They also coordinate reactions to injury, stress, and infection.

The enhancement of cytokine production represents a critical aspect of Ipamorelin’s immunomodulatory effects. Cytokines are essential signaling molecules that orchestrate immune responses and tissue repair processes throughout the body.

White Blood Cell Production

CJC 1295 Ipamorelin can also help enhance the body’s immune function by increasing the production of white blood cells. This can help the body better fight off infections and illnesses.5

By stimulating white blood cell production, Ipamorelin provides fundamental support for the adaptive immune system, enhancing the body’s capacity to recognize and eliminate pathogens.

Clinical Applications in Immunocompromised Populations

Ipamorelin therapies can also result in greater immune system function, which helps to stave off disease. Like many other growth hormone peptide therapies, ipamorelin is commonly used in patients with HIV to improve their immune systems.

This clinical application demonstrates the practical immunomodulatory benefits of Ipamorelin, particularly for individuals with compromised immune function who require enhanced defensive capabilities.

Growth Hormone and Immune Cell Function

Ipamorelin benefits include building lean muscle mass, maintaining healthy bones, improving digestive health, supporting heart health, improving blood sugar levels, strengthening the immune system, preventing cognitive decline, enhancing sex drive and sexual function, promoting tissue regeneration, and improving sleep quality. General Health Improvements: Ipamorelin strengthens the immune system, supports heart health, improves sleep quality, and may prevent cognitive decline, offering a wide range of health benefits.

The comprehensive enhancement of immune function through Ipamorelin therapy provides robust protection against pathogens while supporting the body’s natural defensive mechanisms.

Selectivity and Safety for Immune Balance

Very surprisingly, ipamorelin did not release ACTH or cortisol in levels significantly different from those observed following GHRH stimulation. This lack of effect on ACTH and cortisol plasma levels was evident even at doses more than 200-fold higher than the ED50 for GH release. In conclusion, ipamorelin is the first GHRP-receptor agonist with a selectivity for GH release similar to that displayed by GHRH.

This remarkable selectivity means that Ipamorelin can enhance immune function without triggering the immunosuppressive effects associated with elevated cortisol levels, making it particularly valuable for immune modulation.